Joachim Koerner, director e-Device, R&D Prescription Division, Aptar Pharma, discusses intranasal drug delivery and how an integrated electronic lockout device can assist with patient adherence and help prevent drug misuse.
According to a survey released by Tufts Center for the Study of Drug Development, ‘2017 eClinical Landscape Study’, the length of time it takes companies to build and release a clinical study database is having a negative effect on trial completion
Here, Fran DeGrazio, vice president of Scientific Affairs & Technical Services at West Pharmaceutical Services, runs through key considerations and how specific designs can help with patient adherence.
Here, Michael Merges, Catalent Biologics, and Brian Fahie, Biogen, discuss the growing need for partners who can provide niche technologies to accelerate development projects.
In this article Robert L. Moore, PhD, from Cryoport Services discusses the key considerations of manufacturing biologics in a commercial environment and the benefits of intelligent logistics.
In this article Steve Lam, senior vice president and head of biologics, Patheon, looks at which choice is best when developing a biomanufacturing strategy.
A new life sciences survey has revealed near-universal agreement across the industry that clinical systems and processes must be streamlined to improve study speed and quality. Here, Rik Van Mol tells us more…
In this article, François Feig, head of Global General Medicine and Endocrinology, Merck, explores technological advancements in healthcare and how they can be used to improve patients’ lives.
Digital health is a major trend topic in pharma with many companies investing in the field and looking at ways the tech can be utilised. In this Q&A, Norbert Haberland speaks about how Datwyler is taking on the challenges of this advancing field
We talk to Rupert Taylor, global category manager — Healthcare & Personal Care, about the importance of patient adherence and the various design features that help make packaging safe, simple and specialised.
Head of operations at Sharp Clinical Services, Dave Wilson, reveals how automating packaging lines can benefit clinical trial supply and what should be considered before introducing new technology.
